Go homepage(回首页) Upload pictures (上传图片) Write articles (发文字帖)
The author:(作者)aaapublished in(发表于) 2013/12/16 0:37:39 Hunan 2 infant deaths after hepatitis b vaccine， vaccine in question is disabled
Authorities wide nets in changning, December 14 (Xinhua Fu Lei) Yonge-Canton news, according to the voice of China reported that recently, Changning, Hunan province, Hengshan County, hanshou County, 3 baby serious adverse reactions after immunization with hepatitis b vaccine. Among them, changning and Hengshan two babies who died, hanshou a baby still in intensive care in the hospital room for treatment.
According to understanding, involved thing of vaccine callout for Shenzhen kangtai Bio Corporation production of restructuring b type hepatitis vaccine, through the company of website, we found this company is established Yu August 1988, is Shenzhen first high-tech enterprise one, main is engaged in Yu bio of research production and sales, currently the enterprise has became China maximum of hepatitis b vaccine production enterprise, products cover national 31 a provinces Prefecture, market share is reached has 50% above,
On December 11, the Hunan Provincial Public Security Bureau of Hunan provincial CDC and the Hunan provincial Department of public security has set up an expert group to look into the matter, and existence of breaches in healthcare workers were vaccinated in the conduct of investigations. Hunan provincial Office of the Centers for disease control, researchers said specific issues have not find out, will take some time, because the vaccine is not only production, and moisturizing requirements in areas such as transport and preservation, as well as insulation, to thoroughly investigate the entire chain, and 3 babies symptoms of adverse reactions is not consistent.
According to the Hunan provincial Center for disease control Office personnel, Changning infant before his death without any symptoms of discomfort, Hengyang, hengsh reaction of vomiting and crying babies, low-grade fever, vaccination died one day later. Hanshou County infant was diagnosed with intestinal necrosis may not directly associated with the vaccination.
CDC Office of Hunan province said that if adverse reactions, it may well be a problem with the vaccine, but poor response inconsistency, there may be individual cases, the relationship between vaccination and not sure.
At present, Hunan province and Hunan provincial Center for disease control and the Department of health has organized experts to investigate the matter, the results will be made public as soon as possible. In order to control the drugs risks, temporary suspension of Hunan province, Shenzhen kangtai biological products company limited batch of Phytophthora C201207088 and recombinant hepatitis b C201207090.
(Original title: two infants died after immunization with hepatitis b vaccine in Hunan involved vaccine is deactivated)
央广网常宁12月14日消息(记者 傅蕾) 据中国之声《央广新闻》报道，近日，湖南省常宁市、衡山县、汉寿县共有3名婴儿在接种乙肝疫苗后出现严重不良反应。其中，常宁和衡山的两名婴儿不幸死亡，汉寿的一名婴儿仍在医院重症监护室抢救。
据了解，涉事的疫苗标注为深圳康泰生物制品股份有限公司生产的重组乙型肝炎疫苗，通过该公司的网站，我们发现这个公司是成立于1988年8月，是深圳市首批高新技术企业之一，主要是从事于生物制品的研发生产和销售，目前该企业已经成为中国最大的乙肝疫苗生产企业，产品覆盖全国31个省市自治州，市场占有率是达到了50%以上，
在12月11日，湖南省公安厅湖南省疾控中心和湖南省公安厅已经成立了专家组调查此事，同时对于医护人员在注射疫苗中是否存在违规操作也在进行调查。湖南省疾控中心的办公室人员称，具体问题还没有查清楚，需要一段时间，因为疫苗不仅仅是生产，还有运输和保存以及保温保湿等方面的要求，要彻查整个链条，而且3名婴儿的不良反应症状并不一致。
据湖南省疾控中心办公人员介绍，常宁市的婴儿在死亡前没有任何不适的症状，衡阳市衡山县婴儿出现了呕吐和哭闹的反应，有低烧，在注射疫苗一天以后死亡。另外汉寿县婴儿被诊断为肠坏死，可能与疫苗接种没有直接关联。
湖南省疾控中心办公人员说，如果不良反应一致，就很可能是疫苗接种出现了问题，但是不良反应不一致，就有可能是个别案例，与疫苗接种的关系还不确定。
目前湖南省卫生厅和湖南省疾控中心已经组织专家调查此事，结果将会尽快向社会公布。为了控制用药风险，湖南省暂停使用深圳康泰生物制品股份有限公司批号为为C201207088和C201207090的重组乙型肝炎疫。
(原标题：湖南两名婴儿接种乙肝疫苗后死亡 涉事疫苗被停用)
赞